Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Clinical trial NCT00396149 · COMPLETED

Trial details

NCT number: NCT00396149
Sponsor: Stallergenes Greer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Birch Pollen-Related Rhinoconjunctivitis Rhinitis, Allergic, Seasonal

Start date: 2006-11-01
Primary completion: 2007-03-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.